# Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity

> **NCT03943134** · — · TERMINATED · sponsor: **Axogen Corporation** · enrollment: 7 (actual)

## Conditions studied

- Acute Upper Extremity Trauma

## Interventions

- **OTHER:** Minimally Processed Human Umbilical Cord Membrane
- **OTHER:** Standard Surgical Procedures

## Key facts

- **NCT ID:** NCT03943134
- **Lead sponsor:** Axogen Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-01
- **Primary completion:** 2020-12-17
- **Final completion:** 2020-12-17
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Axogen suspended market availability of the Avive® Soft Tissue Membrane effective June 1, 2021. This decision was not related to any safety concerns or product quality issues.
- **Last updated:** 2025-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943134, "Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03943134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*